Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al
- PMID: 37229793
- DOI: 10.1002/art.42618
Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al
Comment in
-
Reply.Arthritis Rheumatol. 2023 Nov;75(11):2065-2066. doi: 10.1002/art.42621. Epub 2023 Oct 22. Arthritis Rheumatol. 2023. PMID: 37229791 No abstract available.
Comment on
-
Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-Based Study.Arthritis Rheumatol. 2023 Mar;75(3):475-484. doi: 10.1002/art.42337. Epub 2023 Jan 11. Arthritis Rheumatol. 2023. PMID: 36054570
References
-
- Hoque MR, Lu L, Daftarian N, et al. Risk of arrhythmia among new users of hydroxychloroquine in rheumatoid arthritis and systemic lupus erythematosus: a population-based study. Arthritis Rheumatol 2023;75:475-84.
-
- Desmarais J, Rosenbaum JT, Costenbader KH, et al. American College of Rheumatology white paper on antimalarial cardiac toxicity. Arthritis Rheumatol 2021;73:2151-60.
-
- Hooks M, Bart B, Vardeny O, et al. Effects of hydroxychloroquine treatment on QT interval. Heart Rhythm 2020;17:1930-5.
-
- Goldman A, Bomze D, Dankner R, et al. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: a comprehensive pharmacovigilance analysis of pre-COVID-19 reports. Br J Clin Pharmacol 2021;87:1432-42.
-
- Nguyen LS, Dolladille C, Drici MD, et al. Cardiovascular toxicities associated with hydroxychloroquine and azithromycin: an analysis of the World Health Organization pharmacovigilance database. Circulation 2020;142:303-5.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
